Nomura Holdings
TTPH

Nomura Holdings’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Nomura Holdings’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-12,658
Closed -$4.86M – 2869
2014
Q3 		$4.86M Buy
+12,658
New +$3.39M 0.01% 706

Other funds holding TTPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
IG
ING Group Amsterdam, Netherlands $16.4B AUM 34.6% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Nomura Holdings's TTPH Position: Q4 2014 in Review

Nomura Holdings sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q4 2014, closing a stake of 12,658 shares — an estimated $4.86M sold.

Nomura Holdings first reported a position in TTPH in Q3 2014 and held it in 1 quarter. The position peaked at $4.86M in Q3 2014. 96 funds tracked by Wall St. Rank hold TTPH as of Q4 2014.

  • Nomura Holdings reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q4 2014 after selling out during the quarter.
  • Nomura Holdings sold 12,658 Tetraphase Pharmaceuticals, Inc. shares in Q4 2014, an estimated $4.86M.
  • Nomura Holdings first reported a position in Tetraphase Pharmaceuticals, Inc. in Q3 2014 and held it in 1 quarter.
  • Nomura Holdings's Tetraphase Pharmaceuticals, Inc. position peaked at $4.86M in Q3 2014.
  • 96 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q4 2014.

Based on Nomura Holdings's 13F filing for Q4 2014, filed 17 Feb 2015.